T-LBL
Showing 1 - 25 of 8,041
T-lymphoblastic Lymphoma, T-ALL Trial in Shanghai (CAR-T)
Recruiting
- T-lymphoblastic Lymphoma
- T-ALL
- CAR-T
-
Shanghai, ChinaShanghai Ruijin Hospital
Nov 14, 2023
T Cell Lymphoblastic Lymphoma Trial in Beijing (BT-007 CD7 CAR-T cells)
Recruiting
- T Cell Lymphoblastic Lymphoma
- BT-007 CD7 CAR-T cells
-
Beijing, ChinaBeijing Cancer Hospital
Sep 22, 2022
Leukemia, T Cell Trial in Beijing (CD7 CART)
Recruiting
- Leukemia, T Cell
- CD7 CART
-
Beijing, Hebei, ChinaHe bei Yan da Lu dao pei Hospital
May 24, 2022
Tumors, Hematologic Tumors, Hematologic Diseases Trial in Hefei (RD13-02 cell infusion)
Recruiting
- Neoplasms
- +2 more
- RD13-02 cell infusion
-
Hefei, Anhui, ChinaThe First Affiliated Hospital of University of Science and Techn
Jun 5, 2023
Tumors, Hematologic Tumors, Tumors by Site Trial in Hangzhou (RD13-02 cell infusion)
Recruiting
- Neoplasms
- +3 more
- RD13-02 cell infusion
-
Hangzhou, Zhejiang, ChinaThe first affiliated hospital of medical college of zhejiang uni
Feb 6, 2023
T-cell Acute Lymphoblastic Leukemia/Lymphoma Trial in Beijing (Senl-T7)
Recruiting
- T-cell Acute Lymphoblastic Leukemia/Lymphoma
- Senl-T7
-
Beijing, Hebei, ChinaHebei yanda Hospital
Nov 22, 2022
T-cell Acute Lymphoblastic Leukemia, T-lymphoblastic Lymphoma Trial in Kunming (Target CD7 CAR-T cells)
Withdrawn
- T-cell Acute Lymphoblastic Leukemia
- T-lymphoblastic Lymphoma
- Target CD7 CAR-T cells
-
Kunming, Yunnan, China920th Hospital of Joint Logistics Support Force of People's Libe
Nov 23, 2022
T-cell Lymphoblastic Lymphoma Trial in Shanghai, Chengdu (Prednisone,Vincristine, Pegylated-asparaginase, Bortezomib,Cytarabine,
Not yet recruiting
- T-cell Lymphoblastic Lymphoma
- Prednisone,Vincristine, Pegylated-asparaginase, Bortezomib,Cytarabine, Cyclophosphamide, Daunorubicin, 6-mercaptopurine, methotrexate, Dexamethasone, Doxorubicin
- Prednisone,Vincristine, Pegylated-asparaginase, Bortezomib,Cytarabine, Cyclophosphamide, Daunorubicin, 6-mercaptopurine, methotrexate, Dexamethasone, Doxorubicin, Vindesine, Etoposide, Ifosfamide
-
Shanghai, Shanghai, China
- +1 more
Dec 27, 2022
Leukemia, Lymphoblastic, Leukemia Trial in Houston (CB-103, Venetoclax)
Not yet recruiting
- Leukemia, Lymphoblastic
- Leukemia
-
Houston, TexasMD Anderson Cancer Center
Jul 19, 2022
Tumors, Hematologic Tumors, Hematologic Diseases Trial in Xuzhou (RD13-02 cell infusion)
Recruiting
- Neoplasms
- +2 more
- RD13-02 cell infusion
-
Xuzhou, Jiangsu, ChinaAffiliated hospital of Xuzhou medical college
Jun 7, 2023
T-cell Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma Trial in Australia, United States (WU-CART-007)
Recruiting
- T-cell Acute Lymphoblastic Leukemia
- Lymphoblastic Lymphoma
- WU-CART-007
-
Duarte, California
- +7 more
Jun 22, 2022
Cytarabine+Thiotepa + Fludarabine + Busulfan, T Cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma Trial in Hangzhou
Recruiting
- Cytarabine+Thiotepa + Fludarabine + Busulfan
- T Cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma
- cytarabine+thiotepa+ fludarabine + busulfan
-
Hangzhou, ChinaThe First Affiliated Hospital, College of Medicine, Zhejiang Uni
Oct 26, 2022
T-cell Type Acute Leukemia-Precursor, T-lymphoblastic Lymphoma/Leukaemia Trial in Worldwide (Isatuximab SAR650984,
Terminated
- T-cell Type Acute Leukemia-Precursor
- T-lymphoblastic Lymphoma/Leukaemia
- Isatuximab SAR650984
- +4 more
-
Atlanta, Georgia
- +16 more
Mar 10, 2022
T Acute Lymphoblastic Leukemia, T-lymphoblastic Lymphoma Trial in Langfang (RD13-01 cell infusion)
Unknown status
- T Acute Lymphoblastic Leukemia
- T-lymphoblastic Lymphoma
- RD13-01 cell infusion
-
Langfang, Hebei, ChinaHebei Yanda Ludaopei Hospital
Nov 3, 2020
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma Trial (Cladribine)
Not yet recruiting
- Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
- (no location specified)
Dec 17, 2020
Induction Chemo, Acute T-Lymphocytic Leukemia, T-cell Lymphoblastic Lymphoma Leukemia Trial in Suzhou (Decitabine combined with
Recruiting
- Induction Chemotherapy
- +3 more
- Decitabine combined with HAAG Regimen
-
Suzhou, Jiangsu, ChinaThe First Affiliated Hospital of Soochow University
Jun 22, 2020
Acute Myeloid Leukemia, T Cell Acute Lymphoblastic Leukemia, T Cell Lymphoblastic Lymphoma Trial in Milwaukee (XmAb18968 - Dose
Recruiting
- Acute Myeloid Leukemia
- +2 more
- XmAb18968 - Dose level -1
- +4 more
-
Milwaukee, WisconsinFroedtert Hospital & the Medical College of Wisconsin
Feb 15, 2022
T-Cell Acute Lymphocytic Leukemia Trial in Langfang (CD7 CAR-T)
Recruiting
- T-Cell Acute Lymphocytic Leukemia
- CD7 CAR-T
-
Langfang, Hebei, ChinaHebei Yanda Hospital
Jun 26, 2023
Acute Lymphoblastic Leukemia, Lymphoblastic Leukemia Trial in Canada, United States (IM JZP-458, IV JZP-458)
Completed
- Acute Lymphoblastic Leukemia
- Lymphoblastic Leukemia
- IM JZP-458
- IV JZP-458
-
Birmingham, Alabama
- +73 more
Aug 3, 2022
Unresectable or Metastatic Microsatellite Stable/Mismatch Repair Proficient Colorectal Cancer Trial in Australia, China
Recruiting
- Unresectable or Metastatic Microsatellite Stable/Mismatch Repair Proficient Colorectal Cancer
- LBL-007
- +3 more
-
Benowa, Queensland, Australia
- +7 more
Jan 30, 2023
Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Recurrent, Lymphoblastic
Not yet recruiting
- Acute Lymphoblastic Leukemia
- +4 more
- Dasatinib
- +5 more
-
Utrecht, NetherlandsPrincess Máxima Center for Pediatric Oncology
Feb 20, 2023
Acute Lymphoblastic Leukemia, in Relapse, Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Recurrent,
Not yet recruiting
- Acute Lymphoblastic Leukemia, in Relapse
- +4 more
- Ruxolitinib
- +5 more
-
Utrecht, NetherlandsPrincess Máxima Center for Pediatric Oncology
Feb 16, 2023
Acute Lymphoblastic Leukemia, in Relapse, Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Recurrent,
Not yet recruiting
- Acute Lymphoblastic Leukemia, in Relapse
- +4 more
- Decitabine
- +3 more
-
Utrecht, NetherlandsPrincess Máxima Center for Pediatric Oncology
Feb 22, 2023
Acute Lymphoblastic Leukemia, in Relapse, Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Recurrent,
Not yet recruiting
- Acute Lymphoblastic Leukemia, in Relapse
- +4 more
- Trametinib
- +4 more
-
Utrecht, NetherlandsPrincess Máxima Center for Pediatric Oncology
Dec 13, 2022
T Acute Lymphoblastic Leukemia, Early T Acute Lymphoblastic Leukemia, T-lymphoblastic Lymphoma Trial in Italy (bone marrow
Recruiting
- T Acute Lymphoblastic Leukemia
- +3 more
- bone marrow and/or peripheral blood samples withdrawal
-
Ancona, Italy
- +9 more
Nov 24, 2022